Surinder K. Batra - Publications

Affiliations: 
Biochemistry and Molecular Biology University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Cell Biology, Molecular Biology, Biochemistry, Oncology

265 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Carmicheal J, Patel A, Dalal V, Atri P, Dhaliwal AS, Wittel UA, Malafa MP, Talmon G, Swanson BJ, Singh S, Jain M, Kaur S, Batra SK. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s). Biochimica Et Biophysica Acta. Reviews On Cancer. 188318. PMID 31676330 DOI: 10.1016/j.bbcan.2019.188318  0.56
2019 Ernani V, Jahan R, Smith LM, Marr AS, Kimbrough SE, Kos ME, Tijerina J, Pivovar S, Lakshmanan I, Ketcham M, Rauth S, Mallya K, Nasser MW, Jain M, Kessinger A, ... Batra SK, et al. A phase I study of weekly doxorubicin and oral topotecan for patients with relapsed or refractory small cell lung cancer (SCLC): A Fred and Pamela Buffet Cancer Center Clinical Trials Network study. Cancer Treatment and Research Communications. 22: 100162. PMID 31675535 DOI: 10.1016/j.ctarc.2019.100162  0.6
2019 Hein AL, Brandquist ND, Ouellette CY, Seshacharyulu P, Enke CA, Ouellette MM, Batra SK, Yan Y. PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells. Oncogenesis. 8: 63. PMID 31659153 DOI: 10.1038/s41389-019-0172-9  0.32
2019 Dalal V, Carmicheal J, Dhaliwal A, Jain M, Kaur S, Batra SK. Radiomics in stratification of pancreatic cystic lesions: Machine learning in action. Cancer Letters. PMID 31629933 DOI: 10.1016/j.canlet.2019.10.023  0.56
2019 Gurumurthy CB, O'Brien AR, Quadros RM, Adams J, Alcaide P, Ayabe S, Ballard J, Batra SK, Beauchamp MC, Becker KA, Bernas G, Brough D, Carrillo-Salinas F, Chan W, Chen H, et al. Reproducibility of CRISPR-Cas9 methods for generation of conditional mouse alleles: a multi-center evaluation. Genome Biology. 20: 171. PMID 31446895 DOI: 10.1186/s13059-019-1776-2  0.88
2019 Zhang W, Fan W, Rachagani S, Zhou Z, Lele SM, Batra SK, Garrison JC. Comparative Study of Subcutaneous and Orthotopic Mouse Models of Prostate Cancer: Vascular Perfusion, Vasculature Density, Hypoxic Burden and BB2r-Targeting Efficacy. Scientific Reports. 9: 11117. PMID 31366895 DOI: 10.1038/s41598-019-47308-z  0.48
2019 Banerjee K, Gautam SK, Kshirsagar P, Ross KA, Spagnol G, Sorgen P, Wannemuehler MJ, Narasimhan B, Solheim JC, Kumar S, Batra SK, Jain M. Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells. Genes & Cancer. 10: 52-62. PMID 31258832 DOI: 10.18632/genesandcancer.189  0.36
2019 Vengoji R, Macha MA, Nimmakayala RK, Rachagani S, Siddiqui JA, Mallya K, Gorantla S, Jain M, Ponnusamy MP, Batra SK, Shonka N. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells. Journal of Experimental & Clinical Cancer Research : Cr. 38: 266. PMID 31215502 DOI: 10.1186/s13046-019-1264-2  0.88
2019 Jahan R, Ganguly K, Smith LM, Atri P, Carmicheal J, Sheinin Y, Rachagani S, Natarajan G, Brand RE, Macha MA, Grandgenett PM, Kaur S, Batra SK. Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer. Ebiomedicine. PMID 30956167 DOI: 10.1016/j.ebiom.2019.03.056  0.56
2019 Seshacharyulu P, Rachagani S, Muniyan S, Siddiqui JA, Cruz E, Sharma S, Krishnan R, Killips BJ, Sheinin Y, Lele SM, Smith LM, Talmon GA, Ponnusamy MP, Datta K, Batra SK. FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis. Oncogene. PMID 30914801 DOI: 10.1038/s41388-019-0791-9  0.88
2019 Khatri I, Ganguly K, Sharma S, Carmicheal J, Kaur S, Batra SK, Bhasin MK. Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis. Scientific Reports. 9: 123. PMID 30644396 DOI: 10.1038/s41598-018-36328-w  0.56
2019 Bhatia R, Gautam SK, Cannon A, Thompson C, Hall BR, Aithal A, Banerjee K, Jain M, Solheim JC, Kumar S, Batra SK. Cancer-associated mucins: role in immune modulation and metastasis. Cancer Metastasis Reviews. PMID 30618016 DOI: 10.1007/s10555-018-09775-0  0.36
2019 Chaudhary S, Ganguly K, Muniyan S, Pothuraju R, Sayed Z, Jones DT, Batra SK, Macha MA. Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity. Journal of the National Cancer Institute. PMID 30615137 DOI: 10.1093/jnci/djy207  0.4
2018 Uz M, Kalaga M, Pothuraju R, Ju J, Junker WM, Batra SK, Mallapragada S, Rachagani S. Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. 294: 237-246. PMID 30576747 DOI: 10.1016/j.jconrel.2018.12.031  0.48
2018 Pothuraju R, Rachagani S, Junker WM, Chaudhary S, Saraswathi V, Kaur S, Batra SK. Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting. Journal of Experimental & Clinical Cancer Research : Cr. 37: 319. PMID 30567565 DOI: 10.1186/s13046-018-0963-4  0.56
2018 Carmicheal J, Hayashi C, Huang X, Liu L, Lu Y, Krasnoslobodtsev A, Lushnikov A, Kshirsagar PG, Patel A, Jain M, Lyubchenko YL, Lu Y, Batra SK, Kaur S. Label-free characterization of exosome via surface enhanced Raman spectroscopy for the early detection of pancreatic Cancer. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 30550805 DOI: 10.1016/j.nano.2018.11.008  0.56
2018 Vengoji R, Ponnusamy MP, Rachagani S, Mahapatra S, Batra SK, Shonka N, Macha MA. Novel Therapies Hijack the Blood Brain Barrier to Eradicate Glioblastoma Cancer Stem Cells. Carcinogenesis. PMID 30475990 DOI: 10.1093/carcin/bgy171  0.88
2018 Barkeer S, Chugh S, Karmakar S, Kaushik G, Rauth S, Rachagani S, Batra SK, Ponnusamy MP. Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells. Bmc Cancer. 18: 1157. PMID 30466404 DOI: 10.1186/s12885-018-5074-2  0.88
2018 Nimmakayala RK, Batra SK, Ponnusamy MP. Unraveling the journey of cancer stem cells from origin to metastasis. Biochimica Et Biophysica Acta. Reviews On Cancer. 1871: 50-63. PMID 30419314 DOI: 10.1016/j.bbcan.2018.10.006  0.88
2018 Carmicheal J, Kaur S, Batra SK, Ganti AK. Hunting for transcription factors: STAT3 decoy in non-small cell lung cancer. Translational Lung Cancer Research. 7: S254-S257. PMID 30393616 DOI: 10.21037/tlcr.2018.09.06  0.56
2018 Hall BR, Cannon A, Atri P, Wichman CS, Smith LM, Kumar S, Batra SK, Wang H, Ganti AK, Sasson AR, Are C. A Comparative Analysis of Survival and Funding Discrepancies in Cancers with High Mortality. Annals of Surgery. PMID 30188400 DOI: 10.1097/SLA.0000000000003042  0.44
2018 Cannon A, Thompson C, Hall BR, Jain M, Kumar S, Batra SK. Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential. Genes & Cancer. 9: 78-86. PMID 30108679 DOI: 10.18632/genesandcancer.171  0.36
2018 Chugh S, Barkeer S, Rachagani S, Nimmakayala RK, Perumal N, Pothuraju R, Atri P, Mahapatra S, Thapa I, Talmon GA, Smith LM, Yu X, Neelamegham S, Fu J, Xia L, ... ... Batra SK, et al. Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice. Gastroenterology. PMID 30086262 DOI: 10.1053/j.gastro.2018.08.007  0.88
2018 Barkeer S, Chugh S, Batra SK, Ponnusamy MP. Glycosylation of Cancer Stem Cells: Function in Stemness, Tumorigenesis, and Metastasis. Neoplasia (New York, N.Y.). 20: 813-825. PMID 30015157 DOI: 10.1016/j.neo.2018.06.001  0.88
2018 Aithal A, Rauth S, Kshirsagar P, Shah A, Lakshmanan I, Junker WM, Jain M, Ponnusamy MP, Batra SK. MUC16 as a Novel Target for Cancer Therapy. Expert Opinion On Therapeutic Targets. PMID 29999426 DOI: 10.1080/14728222.2018.1498845  0.88
2018 Nimmakayala RK, Seshacharyulu P, Lakshmanan I, Rachagani S, Chugh S, Karmakar S, Rauth S, Vengoji R, Atri P, Talmon GA, Lele SM, Smith LM, Thapa I, Bastola D, Ouellette MM, ... Batra SK, et al. Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1. Gastroenterology. PMID 29864419 DOI: 10.1053/j.gastro.2018.05.041  0.88
2018 Jahan R, Macha MA, Rachaghani S, Das S, Smith LM, Kaur S, Batra SK. Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway. Biochimica Et Biophysica Acta. PMID 29777904 DOI: 10.1016/j.bbadis.2018.05.008  0.56
2018 Vengoji R, Macha MA, Batra SK, Shonka NA. Natural products: a hope for glioblastoma patients. Oncotarget. 9: 22194-22219. PMID 29774132 DOI: 10.18632/oncotarget.25175  0.4
2018 Kaushik G, Ponnusamy MP, Batra SK. Current Status of 3-D Organoids as Pre-Clinical Models. Stem Cells (Dayton, Ohio). PMID 29770526 DOI: 10.1002/stem.2852  0.88
2018 Hall BR, Cannon A, Atri P, Wichman CS, Smith LM, Ganti AK, Are C, Sasson AR, Kumar S, Batra SK. Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years. Oncotarget. 9: 19396-19405. PMID 29721211 DOI: 10.18632/oncotarget.25036  0.44
2018 Aithal A, Junker WM, Kshirsagar P, Das S, Kaur S, Orzechowski C, Gautam SK, Jahan R, Sheinin YM, Lakshmanan I, Ponnusamy MP, Batra SK, Jain M. Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer. Plos One. 13: e0193907. PMID 29708979 DOI: 10.1371/journal.pone.0193907  0.88
2018 Saxena S, Hayashi Y, Wu L, Awaji M, Atri P, Varney ML, Purohit A, Rachagani S, Batra SK, Singh RK. Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis. Oncotarget. 9: 5931-5943. PMID 29464045 DOI: 10.18632/oncotarget.23644  0.48
2018 Qazi AK, Siddiqui JA, Jahan R, Chaudhary S, Walker LA, Syed Z, Jones DT, Batra SK, Macha MA. Emerging Therapeutic Potential of Graviola and its Constituents in Cancers. Carcinogenesis. PMID 29462271 DOI: 10.1093/carcin/bgy024  0.4
2018 Krishn SR, Ganguly K, Kaur S, Batra SK. Ramifications of Secreted Mucin MUC5AC in Malignant Journey: A Holistic View. Carcinogenesis. PMID 29415129 DOI: 10.1093/carcin/bgy019  0.56
2018 Karmakar S, Dey P, Vaz AP, Bhaumik SR, Ponnusamy MP, Batra SK. PD2/PAF1 at the Crossroads of the Cancer Network. Cancer Research. PMID 29311159 DOI: 10.1158/0008-5472.CAN-17-2175  0.88
2018 Kanteti R, Mirzapoiazova T, Riehm JJ, Dhanasingh I, Mambetsariev B, Wang J, Kulkarni P, Kaushik G, Seshacharyulu P, Ponnusamy MP, Kindler HL, Nasser MW, Batra SK, Salgia R. Focal Adhesion Kinase a Potential Therapeutic Target for Pancreatic Cancer and Malignant Pleural Mesothelioma. Cancer Biology & Therapy. 0. PMID 29303405 DOI: 10.1080/15384047.2017.1416937  0.88
2017 Banerjee K, Kumar S, Ross KA, Gautam S, Poelaert B, Nasser MW, Aithal A, Bhatia R, Wannemuehler MJ, Narasimhan B, Solheim JC, Batra SK, Jain M. Emerging trends in the immunotherapy of pancreatic cancer. Cancer Letters. PMID 29242097 DOI: 10.1016/j.canlet.2017.12.012  0.36
2017 Karmakar S, Kaushik G, Nimmakayala R, Rachagani S, Ponnusamy MP, Batra SK. MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention. Seminars in Cancer Biology. PMID 29199014 DOI: 10.1016/j.semcancer.2017.11.020  0.88
2017 Ferdoush J, Karmakar S, Barman P, Kaja A, Uprety B, Batra SK, Bhaumik SR. Ubiquitin-proteasome system regulation of an evolutionarily conserved RNA polymerase II-associated factor 1 involved in pancreatic oncogenesis. Biochemistry. PMID 29023102 DOI: 10.1021/acs.biochem.7b00865  0.36
2017 Quadros RM, Miura H, Harms DW, Akatsuka H, Sato T, Aida T, Redder R, Richardson GP, Inagaki Y, Sakai D, Buckley SM, Seshacharyulu P, Batra SK, Behlke MA, Zeiner SA, et al. Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins. Genome Biology. 18: 92. PMID 28511701 DOI: 10.1186/s13059-017-1220-4  0.32
2017 Gautam SK, Kumar S, Cannon A, Hall B, Bhatia R, Nasser MW, Mahapatra S, Batra S, Jain M. MUC4 Mucin- A Therapeutic Target for Pancreatic Ductal Adenocarcinoma. Expert Opinion On Therapeutic Targets. PMID 28460571 DOI: 10.1080/14728222.2017.1323880  0.36
2017 Macha MA, Rachagani S, Qazi AK, Jahan R, Gupta S, Patel A, Seshacharyulu P, Lin C, Li S, Wang S, Verma V, Kishida S, Kishida M, Nakamura N, Kibe T, ... ... Batra SK, et al. Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells. Oncotarget. 8: 20961-20973. PMID 28423495 DOI: 10.18632/oncotarget.15468  0.48
2017 Seshacharyulu P, Baine MJ, Souchek JJ, Menning M, Kaur S, Yan Y, Ouellette MM, Jain M, Lin C, Batra SK. Biological determinants of radioresistance and their remediation in pancreatic cancer. Biochimica Et Biophysica Acta. PMID 28249796 DOI: 10.1016/j.bbcan.2017.02.003  0.6
2017 Lakshmanan I, Salfity S, Seshacharyulu P, Rachagani S, Thomas A, Das S, Majhi PD, Nimmakayala RK, Vengoji R, Lele SM, Ponnusamy MP, Batra SK, Ganti AK. MUC16 regulates TSPYL5 for lung cancer cell growth and chemoresistance by suppressing p53. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28196872 DOI: 10.1158/1078-0432.CCR-16-2530  0.88
2017 Karmakar S, Seshacharyulu P, Lakshmanan I, Vaz AP, Chugh S, Sheinin YM, Mahapatra S, Batra SK, Ponnusamy MP. hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells. Oncotarget. PMID 28122356 DOI: 10.18632/oncotarget.14775  0.88
2017 Smolsky J, Kaur S, Hayashi C, Batra SK, Krasnoslobodtsev AV. Surface-Enhanced Raman Scattering-Based Immunoassay Technologies for Detection of Disease Biomarkers. Biosensors. 7. PMID 28085088 DOI: 10.3390/bios7010007  0.56
2016 Kaur S, Smith LM, Patel A, Menning M, Watley DC, Malik SS, Krishn SR, Mallya K, Aithal A, Sasson AR, Johansson SL, Jain M, Singh S, Guha S, Are C, ... ... Batra SK, et al. A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study. The American Journal of Gastroenterology. PMID 27845339 DOI: 10.1038/ajg.2016.482  0.6
2016 Kumar S, Cruz E, Joshi S, Patel A, Jahan R, Batra SK, Jain M. Genetic Variants of Mucins: Unexplored Conundrum. Carcinogenesis. PMID 27838635 DOI: 10.1093/carcin/bgw120  0.36
2016 Krishn SR, Kaur S, Sheinin YM, Smith LM, Gautam SK, Patel A, Jain M, Juvvigunta V, Pai P, Lazenby AJ, Roy HK, Batra SK. Mucins and associated O-glycans based immunoprofile for stratification of colorectal polyps: clinical implication for improved colon surveillance. Oncotarget. PMID 27705923 DOI: 10.18632/oncotarget.12347  0.56
2016 Pai P, Rachagani S, Dhawan P, Sheinin YM, Macha MA, Qazi AK, Chugh S, Ponnusamy MP, Mallya K, Pothuraju R, Batra SK. MUC4 is negatively regulated through the Wnt/β-catenin pathway via the Notch effector Hath1 in colorectal cancer. Genes & Cancer. 7: 154-68. PMID 27551331 DOI: 10.18632/genesandcancer.108  0.88
2016 Muniyan S, Haridas D, Chugh S, Rachagani S, Lakshmanan I, Gupta S, Seshacharyulu P, Smith LM, Ponnusamy MP, Batra SK. MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism. Genes & Cancer. 7: 110-24. PMID 27382435 DOI: 10.18632/genesandcancer.104  0.88
2016 Wang Y, Kumar S, Rachagani S, Sajja BR, Xie Y, Hang Y, Jain M, Li J, Boska MD, Batra SK, Oupický D. Polyplex-mediated inhibition of chemokine receptor CXCR4 and chromatin-remodeling enzyme NCOA3 impedes pancreatic cancer progression and metastasis. Biomaterials. 101: 108-120. PMID 27267632 DOI: 10.1016/j.biomaterials.2016.05.042  0.8
2016 Suklabaidya S, Das B, Ali SA, Jain S, Swaminathan S, Mohanty AK, Panda SK, Dash P, Chakraborty S, Batra SK, Senapati S. Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia. Oncotarget. PMID 27259232 DOI: 10.18632/oncotarget.9729  0.44
2016 Chugh S, Meza J, Sheinin YM, Ponnusamy MP, Batra SK. Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation. British Journal of Cancer. PMID 27187683 DOI: 10.1038/bjc.2016.116  0.8
2016 Joshi S, Cruz E, Rachagani S, Guha S, Brand RE, Ponnusamy MP, Kumar S, Batra SK. Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer. Molecular Oncology. PMID 27185392 DOI: 10.1016/j.molonc.2016.04.007  0.88
2016 Joshi S, Kumar S, Ponnusamy MP, Batra SK. Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survival. Oncogene. PMID 27109098 DOI: 10.1038/onc.2016.119  0.88
2016 Kanteti R, Batra SK, Lennon FE, Salgia R. FAK and paxillin, two potential targets in pancreatic cancer. Oncotarget. PMID 26980710 DOI: 10.18632/oncotarget.8040  0.8
2016 Krishn SR, Kaur S, Smith LM, Johansson SL, Jain M, Patel A, Gautam SK, Hollingsworth MA, Mandel U, Clausen H, Lo WC, Fan WL, Manne U, Batra SK. Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer. Cancer Letters. PMID 26898938 DOI: 10.1016/j.canlet.2016.02.016  0.56
2016 Hein AL, Seshacharyulu P, Rachagani S, Sheinin YM, Ouellette MM, Ponnusamy MP, Mumby MC, Batra SK, Yan Y. PR55α subunit of protein phosphatase 2A supports the tumorigenic and metastatic potential of pancreatic cancer cells by sustaining hyperactive oncogenic signaling. Cancer Research. PMID 26893480 DOI: 10.1158/0008-5472.CAN-15-2119  0.8
2016 Purohit A, Varney M, Rachagani S, Ouellette MM, Batra SK, Singh RK. CXCR2 signaling regulates KRAS (G12D)-induced autocrine growth of pancreatic cancer. Oncotarget. PMID 26771140 DOI: 10.18632/oncotarget.6906  0.48
2016 Pai P, Rachagani S, Dhawan P, Batra SK. Mucins and Wnt/β-catenin Signaling in Gastrointestinal Cancers: An Unholy Nexus. Carcinogenesis. PMID 26762229 DOI: 10.1093/carcin/bgw005  0.48
2015 Krishn SR, Batra SK, Kaur S. Advances in miRNA-Mediated Mucin Regulation. Current Pharmacology Reports. 1: 355-364. PMID 27867838 DOI: 10.1007/s40495-014-0010-x  0.56
2015 Vaz AP, Deb S, Rachagani S, Dey P, Muniyan S, Lakshmanan I, Karmakar S, Smith L, Johansson S, Lele S, Ouellette M, Ponnusamy MP, Batra SK. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma. Oncotarget. PMID 26689992 DOI: 10.18632/oncotarget.6580  0.8
2015 Kaur S, Krishn SR, Rachagani S, Batra SK. Significance of microRNA-based biomarkers for pancreatic cancer. Annals of Translational Medicine. 3: 277. PMID 26605323 DOI: 10.3978/j.issn.2305-5839.2015.10.32  0.56
2015 Pai P, Rachagani S, Lakshmanan I, Macha MA, Sheinin Y, Smith LM, Ponnusamy MP, Batra SK. The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma. Molecular Oncology. PMID 26526617 DOI: 10.1016/j.molonc.2015.10.005  0.8
2015 Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, Uryu K, Pharmer L, ... ... Batra SK, et al. Tumour exosome integrins determine organotropic metastasis. Nature. PMID 26524530 DOI: 10.1038/nature15756  0.8
2015 Rachagani S, Macha MA, Menning MS, Dey P, Pai P, Smith LM, Mo YY, Batra SK. Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model. Oncotarget. PMID 26516699 DOI: 10.18632/oncotarget.5641  0.8
2015 Chugh S, Gnanapragassam VS, Jain M, Rachagani S, Ponnusamy MP, Batra SK. Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets. Biochimica Et Biophysica Acta. 1856: 211-225. PMID 26318196 DOI: 10.1016/j.bbcan.2015.08.003  0.8
2015 Muniyan S, Chen SJ, Lin FF, Wang Z, Mehta PP, Batra SK, Lin MF. ErbB-2 signaling plays a critical role in regulating androgen-sensitive and castration-resistant androgen receptor-positive prostate cancer cells. Cellular Signalling. PMID 26257301 DOI: 10.1016/j.cellsig.2015.08.002  0.8
2015 Ingersoll MA, Lyons AS, Muniyan S, D'Cunha N, Robinson T, Hoelting K, Dwyer JG, Bu XR, Batra SK, Lin MF. Novel Imidazopyridine Derivatives Possess Anti-Tumor Effect on Human Castration-Resistant Prostate Cancer Cells. Plos One. 10: e0131811. PMID 26121643 DOI: 10.1371/journal.pone.0131811  0.8
2015 Das S, Majhi PD, Al-Mugotir MH, Rachagani S, Sorgen P, Batra SK. Membrane proximal ectodomain cleavage of MUC16 occurs in the acidifying Golgi/post-Golgi compartments. Scientific Reports. 5: 9759. PMID 26044153 DOI: 10.1038/srep09759  0.8
2015 Lakshmanan I, Seshacharyulu P, Haridas D, Rachagani S, Gupta S, Joshi S, Guda C, Yan Y, Jain M, Ganti AK, Ponnusamy MP, Batra SK. Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells. Oncotarget. PMID 26035354  0.8
2015 Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, Xiang J, Zhang T, Theilen TM, García-Santos G, Williams C, ... ... Batra SK, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nature Cell Biology. 17: 816-26. PMID 25985394 DOI: 10.1038/ncb3169  0.8
2015 Chari ST, Kelly K, Hollingsworth MA, Thayer SP, Ahlquist DA, Andersen DK, Batra SK, Brentnall TA, Canto M, Cleeter DF, Firpo MA, Gambhir SS, Go VL, Hines OJ, Kenner BJ, et al. Early Detection of Sporadic Pancreatic Cancer: Summative Review. Pancreas. 44: 693-712. PMID 25931254 DOI: 10.1097/MPA.0000000000000368  0.8
2015 Higashi M, Yokoyama S, Yamamoto T, Goto Y, Kitazono I, Hiraki T, Taguchi H, Hashimoto S, Fukukura Y, Koriyama C, Mataki Y, Maemura K, Shinchi H, Jain M, Batra SK, et al. Mucin Expression in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Specimens Is a Useful Prognostic Factor in Pancreatic Ductal Adenocarcinoma. Pancreas. 44: 728-34. PMID 25906442 DOI: 10.1097/MPA.0000000000000362  0.8
2015 Jain S, Suklabaidya S, Das B, Raghav SK, Batra SK, Senapati S. TLR4 activation by lipopolysaccharide confers survival advantage to growth factor deprived prostate cancer cells. The Prostate. 75: 1020-33. PMID 25833062 DOI: 10.1002/pros.22983  0.8
2015 Das S, Rachagani S, Torres-Gonzalez MP, Lakshmanan I, Majhi PD, Smith LM, Wagner KU, Batra SK. Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells. Oncotarget. 6: 5772-87. PMID 25691062  0.8
2015 Seshacharyulu P, Ponnusamy MP, Rachagani S, Lakshmanan I, Haridas D, Yan Y, Ganti AK, Batra SK. Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer. Oncotarget. 6: 5164-81. PMID 25686822  0.88
2015 Mimeault M, Rachagani S, Muniyan S, Seshacharyulu P, Johansson SL, Datta K, Lin MF, Batra SK. Inhibition of hedgehog signaling improves the anti-carcinogenic effects of docetaxel in prostate cancer. Oncotarget. 6: 3887-903. PMID 25682877  0.48
2015 Kumar V, Mondal G, Slavik P, Rachagani S, Batra SK, Mahato RI. Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer. Molecular Pharmaceutics. 12: 1289-98. PMID 25679326 DOI: 10.1021/mp500847s  0.8
2015 Joshi S, Kumar S, Bafna S, Rachagani S, Wagner KU, Jain M, Batra SK. Genetically engineered mucin mouse models for inflammation and cancer. Cancer Metastasis Reviews. PMID 25634251 DOI: 10.1007/s10555-015-9549-1  0.8
2015 Macha MA, Krishn SR, Jahan R, Banerjee K, Batra SK, Jain M. Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer. Cancer Treatment Reviews. 41: 277-88. PMID 25624117 DOI: 10.1016/j.ctrv.2015.01.001  0.8
2015 Pandey P, Rachagani S, Das S, Seshacharyulu P, Sheinin Y, Naslavsky N, Pan Z, Smith BL, Peters HL, Radhakrishnan P, McKenna NR, Giridharan SS, Haridas D, Kaur S, Hollingsworth MA, ... ... Batra SK, et al. Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis. Oncotarget. 6: 2064-75. PMID 25576918  0.8
2015 Rachagani S, Macha MA, Heimann N, Seshacharyulu P, Haridas D, Chugh S, Batra SK. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. Advanced Drug Delivery Reviews. 81: 16-33. PMID 25453266 DOI: 10.1016/j.addr.2014.10.020  0.48
2015 Lakshmanan I, Ponnusamy MP, Macha MA, Haridas D, Majhi PD, Kaur S, Jain M, Batra SK, Ganti AK. Mucins in lung cancer: diagnostic, prognostic, and therapeutic implications. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 19-27. PMID 25319180 DOI: 10.1097/JTO.0000000000000404  0.8
2015 Krasnoslobodtsev AV, Torres MP, Kaur S, Vlassiouk IV, Lipert RJ, Jain M, Batra SK, Lyubchenko YL. Nano-immunoassay with improved performance for detection of cancer biomarkers. Nanomedicine : Nanotechnology, Biology, and Medicine. 11: 167-73. PMID 25200613 DOI: 10.1016/j.nano.2014.08.012  0.8
2015 Kamikawa Y, Kanmura Y, Hamada T, Yamada N, Macha MA, Batra SK, Higashi M, Yonezawa S, Sugihara K. Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma. International Journal of Clinical Oncology. 20: 298-307. PMID 24909613 DOI: 10.1007/s10147-014-0710-6  0.8
2015 Kumar S, Torres MP, Kaur S, Rachagani S, Joshi S, Johansson SL, Momi N, Baine MJ, Gilling CE, Smith LM, Wyatt TA, Jain M, Joshi SS, Batra SK. Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophages. Oncogene. 34: 2052-60. PMID 24909166 DOI: 10.1038/onc.2014.154  0.8
2015 Senapati S, Singh RK, Batra SK. Tumor microenvironment: Blood vascular system in cancer metastasis Systems Biology of Cancer. 309-322. DOI: 10.1017/9780511979811.021  0.44
2015 Das S, Batra SK. Pancreatic cancer metastasis: Are we being pre-EMTed? Current Pharmaceutical Design. 21: 1249-1255.  0.8
2014 Vaz AP, Ponnusamy MP, Seshacharyulu P, Batra SK. A concise review on the current understanding of pancreatic cancer stem cells. Journal of Cancer Stem Cell Research. 2. PMID 26451384  0.88
2014 Shibahara H, Higashi M, Yokoyama S, Rousseau K, Kitazono I, Osako M, Shirahama H, Tashiro Y, Kurumiya Y, Narita M, Kuze S, Hasagawa H, Kato T, Kubota H, Suzuki H, ... ... Batra SK, et al. A comprehensive expression analysis of mucins in appendiceal carcinoma in a multicenter study: MUC3 is a novel prognostic factor. Plos One. 9: e115613. PMID 25551773 DOI: 10.1371/journal.pone.0115613  0.8
2014 Niv Y, Boltin D, Halpern M, Cohen M, Levi Z, Vilkin A, Morgenstern S, Manugian V, St Lawrence E, Gagneux P, Kaur S, Sharma P, Batra SK, Ho SB. Membrane-bound mucins and mucin terminal glycans expression in idiopathic or Helicobacter pylori, NSAID associated peptic ulcers. World Journal of Gastroenterology : Wjg. 20: 14913-20. PMID 25356051 DOI: 10.3748/wjg.v20.i40.14913  0.8
2014 Yan Y, Hein AL, Etekpo A, Burchett KM, Lin C, Enke CA, Batra SK, Cowan KH, Ouellette MM. Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation. Oncotarget. 5: 10251-70. PMID 25344910  0.8
2014 Ponnusamy MP, Batra SK. Insights into the role of nicotine in pancreatic stem cell activation and acinar dedifferentiation. Gastroenterology. 147: 962-5. PMID 25265575 DOI: 10.1053/j.gastro.2014.09.026  0.8
2014 Kakar SS, Ratajczak MZ, Powell KS, Moghadamfalahi M, Miller DM, Batra SK, Singh SK. Withaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells. Plos One. 9: e107596. PMID 25264898 DOI: 10.1371/journal.pone.0107596  0.8
2014 Joshi S, Kumar S, Choudhury A, Ponnusamy MP, Batra SK. Altered Mucins (MUC) trafficking in benign and malignant conditions. Oncotarget. 5: 7272-84. PMID 25261375  0.8
2014 Souchek JJ, Baine MJ, Lin C, Rachagani S, Gupta S, Kaur S, Lester K, Zheng D, Chen S, Smith L, Lazenby A, Johansson SL, Jain M, Batra SK. Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation. British Journal of Cancer. 111: 1139-49. PMID 25025965 DOI: 10.1038/bjc.2014.385  0.8
2014 Vaz AP, Ponnusamy MP, Rachagani S, Dey P, Ganti AK, Batra SK. Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem cells British Journal of Cancer. 111: 486-496. PMID 25003666 DOI: 10.1038/bjc.2014.152  0.8
2014 Haridas D, Ponnusamy MP, Chugh S, Lakshmanan I, Seshacharyulu P, Batra SK. MUC16: Molecular analysis and its functional implications in benign and malignant conditions Faseb Journal. 28: 4183-4199. PMID 25002120 DOI: 10.1096/fj.14-257352  0.8
2014 Chakraborty S, Smith L, Ganti AK, Bonthu N, Batra SK. Author's response to "Country of origin and breast cancer survival". Asia-Pacific Journal of Clinical Oncology. 10: 280. PMID 24965198 DOI: 10.1111/ajco.12212  0.8
2014 Dey P, Rachagani S, Vaz AP, Ponnusamy MP, Batra SK. PD2/Paf1 depletion in pancreatic acinar cells promotes acinar-to-ductal metaplasia. Oncotarget. 5: 4480-91. PMID 24947474  0.8
2014 Muniyan S, Ingersoll MA, Batra SK, Lin MF. Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor. Biochimica Et Biophysica Acta. 1846: 88-98. PMID 24747769 DOI: 10.1016/j.bbcan.2014.04.006  0.8
2014 Shibahara H, Higashi M, Koriyama C, Yokoyama S, Kitazono I, Kurumiya Y, Narita M, Kuze S, Kyokane T, Mita S, Arai T, Kato T, Yuasa N, Yamaguchi R, Kubota H, ... ... Batra SK, et al. Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer. Plos One. 9: e86111. PMID 24722639 DOI: 10.1371/journal.pone.0086111  0.8
2014 Yokoyama S, Kitamoto S, Higashi M, Goto Y, Hara T, Ikebe D, Yamaguchi T, Arisaka Y, Niihara T, Nishimata H, Tanaka S, Takaori K, Batra SK, Yonezawa S. Diagnosis of pancreatic neoplasms using a novel method of DNA methylation analysis of mucin expression in pancreatic juice. Plos One. 9: e93760. PMID 24714692 DOI: 10.1371/journal.pone.0093760  0.8
2014 Kaur S, Momi N, Chakraborty S, Wagner DG, Horn AJ, Lele SM, Theodorescu D, Batra SK. Altered expression of transmembrane mucins, MUC1 and MUC4, in bladder cancer: pathological implications in diagnosis. Plos One. 9: e92742. PMID 24671186 DOI: 10.1371/journal.pone.0092742  0.8
2014 Macha MA, Seshacharyulu P, Krishn SR, Pai P, Rachagani S, Jain M, Batra SK. MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers. Current Pharmaceutical Design. 20: 5287-97. PMID 24479799  0.8
2014 Mimeault M, Batra SK. Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers Cancer Epidemiology Biomarkers and Prevention. 23: 234-254. PMID 24273063 DOI: 10.1158/1055-9965.EPI-13-0785  0.8
2014 Kaur S, Sharma N, Krishn SR, Lakshmanan I, Rachagani S, Baine MJ, Smith LM, Lele SM, Sasson AR, Guha S, Mallya K, Anderson JM, Hollingsworth MA, Batra SK. MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 688-700. PMID 24240113 DOI: 10.1158/1078-0432.CCR-13-2174  0.8
2014 Momi N, Kaur S, Rachagani S, Ganti AK, Batra SK. Smoking and microRNA dysregulation: a cancerous combination. Trends in Molecular Medicine. 20: 36-47. PMID 24238736 DOI: 10.1016/j.molmed.2013.10.005  0.8
2014 Mimeault M, Batra SK. Introduction at the special issue on implications of cancer stem/progenitor cell concepts in molecular oncology and novel targeted therapies. Molecular Aspects of Medicine. 39: 1-2. PMID 24080440 DOI: 10.1016/j.mam.2013.09.001  0.8
2014 Mimeault M, Batra SK. Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies. Molecular Aspects of Medicine. 39: 3-32. PMID 23994756 DOI: 10.1016/j.mam.2013.08.001  0.8
2014 Chakraborty S, Smith L, Ganti AK, Bonthu N, Shimizhu T, Batra SK. Breast cancer survival of Hispanic women in the USA is influenced by country of origin. Asia-Pacific Journal of Clinical Oncology. 10: 124-32. PMID 23551959 DOI: 10.1111/ajco.12063  0.8
2013 Torres MP, Rachagani S, Souchek JJ, Mallya K, Johansson SL, Batra SK. Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy. Plos One. 8: e80580. PMID 24278292 DOI: 10.1371/journal.pone.0080580  0.8
2013 Radhakrishnan P, Mohr AM, Grandgenett PM, Steele MM, Batra SK, Hollingsworth MA. MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer. Plos One. 8: e73356. PMID 24204560 DOI: 10.1371/journal.pone.0073356  0.8
2013 Ponnusamy MP, Seshacharyulu P, Lakshmanan I, Vaz AP, Chugh S, Batra SK. Emerging role of mucins in epithelial to mesenchymal transition. Current Cancer Drug Targets. 13: 945-56. PMID 24168188  0.88
2013 Vaz AP, Ponnusamy MP, Batra SK. Cancer stem cells and therapeutic targets: an emerging field for cancer treatment. Drug Delivery and Translational Research. 3: 113-20. PMID 24077517 DOI: 10.1007/s13346-012-0095-x  0.8
2013 Macha MA, Batra SK, Ganti AK. Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma. Cancer Management and Research. 5: 197-203. PMID 23940421 DOI: 10.2147/CMAR.S45976  0.8
2013 Kitazono I, Higashi M, Kitamoto S, Yokoyama S, Horinouchi M, Osako M, Shimizu T, Tabata M, Batra SK, Goto M, Yonezawa S. Expression of MUC4 mucin is observed mainly in the intestinal type of intraductal papillary mucinous neoplasm of the pancreas. Pancreas. 42: 1120-8. PMID 23921963 DOI: 10.1097/MPA.0b013e3182965915  0.8
2013 Macha MA, Rachagani S, Gupta S, Pai P, Ponnusamy MP, Batra SK, Jain M. Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling. Cancer Letters. 341: 166-77. PMID 23920124 DOI: 10.1016/j.canlet.2013.07.037  0.88
2013 Kaur S, Kumar S, Momi N, Sasson AR, Batra SK. Mucins in pancreatic cancer and its microenvironment. Nature Reviews. Gastroenterology & Hepatology. 10: 607-20. PMID 23856888 DOI: 10.1038/nrgastro.2013.120  0.8
2013 Jain M, Gupta S, Kaur S, Ponnusamy MP, Batra SK. Emerging trends for radioimmunotherapy in solid tumors. Cancer Biotherapy & Radiopharmaceuticals. 28: 639-50. PMID 23844555 DOI: 10.1089/cbr.2013.1523  0.88
2013 Pai P, Rachagani S, Are C, Batra SK. Prospects of miRNA-based therapy for pancreatic cancer. Current Drug Targets. 14: 1101-9. PMID 23834151 DOI: 10.2174/13894501113149990181  0.8
2013 Horn A, Chakraborty S, Dey P, Haridas D, Souchek J, Batra SK, Lele SM. Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology. Archives of Pathology & Laboratory Medicine. 137: 546-51. PMID 23544943 DOI: 10.5858/arpa.2011-0229-OA  0.88
2013 Mimeault M, Batra SK. Development of animal models underlining mechanistic connections between prostate inflammation and cancer. World Journal of Clinical Oncology. 4: 4-13. PMID 23539141 DOI: 10.5306/wjco.v4.i1.4  0.32
2013 Shimizu T, Torres MP, Chakraborty S, Souchek JJ, Rachagani S, Kaur S, Macha M, Ganti AK, Hauke RJ, Batra SK. Holy Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro and in vivo: potential role in therapy. Cancer Letters. 336: 270-80. PMID 23523869 DOI: 10.1016/j.canlet.2013.03.017  0.8
2013 Lin WC, Rajbhandari N, Liu C, Sakamoto K, Zhang Q, Triplett AA, Batra SK, Opavsky R, Felsher DW, DiMaio DJ, Hollingsworth MA, Morris JP, Hebrok M, Witkiewicz AK, Brody JR, et al. Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer. Cancer Research. 73: 1821-30. PMID 23467612 DOI: 10.1158/0008-5472.CAN-12-2067  0.8
2013 Seshacharyulu P, Pandey P, Datta K, Batra SK. Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer. Cancer Letters. 335: 9-18. PMID 23454242 DOI: 10.1016/j.canlet.2013.02.036  0.32
2013 Mimeault M, Johansson SL, Batra SK. Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1. British Journal of Cancer. 108: 1079-91. PMID 23449353 DOI: 10.1038/bjc.2012.484  0.8
2013 Mukhopadhyay P, Lakshmanan I, Ponnusamy MP, Chakraborty S, Jain M, Pai P, Smith LM, Lele SM, Batra SK. MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells. Plos One. 8: e54455. PMID 23408941 DOI: 10.1371/journal.pone.0054455  0.88
2013 Kaur S, Chakraborty S, Baine MJ, Mallya K, Smith LM, Sasson A, Brand R, Guha S, Jain M, Wittel U, Singh SK, Batra SK. Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer. Plos One. 8: e55171. PMID 23383312 DOI: 10.1371/journal.pone.0055171  0.8
2013 Majhi PD, Lakshmanan I, Ponnusamy MP, Jain M, Das S, Kaur S, Shimizu ST, West WW, Johansson SL, Smith LM, Yu F, Rolle CE, Sharma P, Carey GB, Batra SK, et al. Pathobiological implications of MUC4 in non-small-cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 398-407. PMID 23370366 DOI: 10.1097/JTO.0b013e3182829e06  0.8
2013 Gnanapragassam VS, Jain M, Batra SK. Analysis of tumor-associated mucin glycotopes by Western transfer methods. Methods in Molecular Biology (Clifton, N.J.). 980: 331-40. PMID 23359164 DOI: 10.1007/978-1-62703-287-2_19  0.8
2013 Baine MJ, Mallya K, Batra SK. Quantitative real-time PCR expression analysis of peripheral blood mononuclear cells in pancreatic cancer patients. Methods in Molecular Biology (Clifton, N.J.). 980: 157-73. PMID 23359153 DOI: 10.1007/978-1-62703-287-2_8  0.8
2013 Kaur S, Shimizu T, Baine MJ, Kumar S, Batra SK. Immunohistochemistry of pancreatic neoplasia. Methods in Molecular Biology (Clifton, N.J.). 980: 29-42. PMID 23359148 DOI: 10.1007/978-1-62703-287-2_3  0.8
2013 Mimeault M, Batra SK. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells. Journal of Cellular and Molecular Medicine. 17: 30-54. PMID 23301832 DOI: 10.1111/jcmm.12004  0.8
2013 Kaur S, Baine MJ, Guha S, Ochi N, Chakraborty S, Mallya K, Thomas C, Crook J, Wallace MB, Woodward TA, Jain M, Singh S, Sasson AR, Skinner V, Raimondo M, ... Batra SK, et al. Neutrophil gelatinase-associated lipocalin, macrophage inhibitory cytokine 1, and carbohydrate antigen 19-9 in pancreatic juice: pathobiologic implications in diagnosing benign and malignant disease of the pancreas. Pancreas. 42: 494-501. PMID 23146921 DOI: 10.1097/MPA.0b013e31826a8597  0.8
2013 Mimeault M, Batra SK. Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterials. Drug Discovery Today. 18: 128-40. PMID 22903142 DOI: 10.1016/j.drudis.2012.08.002  0.8
2013 Momi N, Ponnusamy MP, Kaur S, Rachagani S, Kunigal SS, Chellappan S, Ouellette MM, Batra SK. Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through α7nAChR-mediated MUC4 upregulation. Oncogene. 32: 1384-95. PMID 22614008 DOI: 10.1038/onc.2012.163  0.8
2013 Chakraborty S, Tarantolo SR, Batra SK, Hauke RJ. Incidence and prognostic significance of second primary cancers in renal cell carcinoma. American Journal of Clinical Oncology. 36: 132-42. PMID 22441339 DOI: 10.1097/COC.0b013e3182438ddf  0.44
2012 Momi N, Kaur S, Krishn SR, Batra SK. Discovering the route from inflammation to pancreatic cancer. Minerva Gastroenterologica E Dietologica. 58: 283-97. PMID 23207606  0.8
2012 Tamura Y, Higashi M, Kitamoto S, Yokoyama S, Osako M, Horinouchi M, Shimizu T, Tabata M, Batra SK, Goto M, Yonezawa S. MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer. Plos One. 7: e49251. PMID 23152882 DOI: 10.1371/journal.pone.0049251  0.8
2012 Rachagani S, Torres MP, Kumar S, Haridas D, Baine M, Macha MA, Kaur S, Ponnusamy MP, Dey P, Seshacharyulu P, Johansson SL, Jain M, Wagner KU, Batra SK. Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy. Journal of Hematology & Oncology. 5: 68. PMID 23102107 DOI: 10.1186/1756-8722-5-68  0.88
2012 Kaur S, Baine MJ, Jain M, Sasson AR, Batra SK. Early diagnosis of pancreatic cancer: challenges and new developments. Biomarkers in Medicine. 6: 597-612. PMID 23075238 DOI: 10.2217/bmm.12.69  0.8
2012 Dey P, Rachagani S, Chakraborty S, Singh PK, Zhao X, Gurumurthy CB, Anderson JM, Lele S, Hollingsworth MA, Band V, Batra SK. Overexpression of ecdysoneless in pancreatic cancer and its role in oncogenesis by regulating glycolysis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 6188-98. PMID 22977192 DOI: 10.1158/1078-0432.CCR-12-1789  0.8
2012 Kitamoto S, Yokoyama S, Higashi M, Yamada N, Matsubara S, Takao S, Batra SK, Yonezawa S. Expression of MUC17 is regulated by HIF1α-mediated hypoxic responses and requires a methylation-free hypoxia responsible element in pancreatic cancer. Plos One. 7: e44108. PMID 22970168 DOI: 10.1371/journal.pone.0044108  0.8
2012 Rachagani S, Macha MA, Ponnusamy MP, Haridas D, Kaur S, Jain M, Batra SK. MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1. Carcinogenesis. 33: 1953-64. PMID 22791819 DOI: 10.1093/carcin/bgs225  0.88
2012 Chen AC, Migliaccio I, Rimawi M, Lopez-Tarruella S, Creighton CJ, Massarweh S, Huang C, Wang YC, Batra SK, Gutierrez MC, Osborne CK, Schiff R. Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies. Breast Cancer Research and Treatment. 134: 583-93. PMID 22644656 DOI: 10.1007/s10549-012-2082-9  0.8
2012 Momi N, Kaur S, Ponnusamy MP, Kumar S, Wittel UA, Batra SK. Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis. Carcinogenesis. 33: 1617-28. PMID 22623649 DOI: 10.1093/carcin/bgs186  0.8
2012 Niv Y, Boltin D, Halpern M, Cohen M, Levi Z, Vilkin A, Morgenstern S, Manugian V, St Lawrence E, Gagneux P, Batra SK, Ho SB. Membrane-bound mucins and mucin terminal glycans expression in idiopathic or Helicobacter pylori, NSAID associated peptic ulcers. Digestive Diseases and Sciences. 57: 2535-44. PMID 22576713 DOI: 10.1007/s10620-012-2205-5  0.8
2012 Kunigal S, Ponnusamy MP, Momi N, Batra SK, Chellappan SP. Nicotine, IFN-γ and retinoic acid mediated induction of MUC4 in pancreatic cancer requires E2F1 and STAT-1 transcription factors and utilize different signaling cascades. Molecular Cancer. 11: 24. PMID 22537161 DOI: 10.1186/1476-4598-11-24  0.8
2012 Kelsey L, Katoch P, Johnson KE, Batra SK, Mehta PP. Retinoids regulate the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. Plos One. 7: e32846. PMID 22514600 DOI: 10.1371/journal.pone.0032846  0.8
2012 Chakraborty S, Kaur S, Guha S, Batra SK. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochimica Et Biophysica Acta. 1826: 129-69. PMID 22513004 DOI: 10.1016/j.bbcan.2012.03.008  0.8
2012 Torres MP, Rachagani S, Purohit V, Pandey P, Joshi S, Moore ED, Johansson SL, Singh PK, Ganti AK, Batra SK. Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism. Cancer Letters. 323: 29-40. PMID 22475682 DOI: 10.1016/j.canlet.2012.03.031  0.8
2012 Mimeault M, Batra SK. Great promise of tissue-resident adult stem/progenitor cells in transplantation and cancer therapies. Advances in Experimental Medicine and Biology. 741: 171-86. PMID 22457110 DOI: 10.1007/978-1-4614-2098-9_12  0.8
2012 Wittel UA, Momi N, Seifert G, Wiech T, Hopt UT, Batra SK. The pathobiological impact of cigarette smoke on pancreatic cancer development (review). International Journal of Oncology. 41: 5-14. PMID 22446714 DOI: 10.3892/ijo.2012.1414  0.8
2012 Mimeault M, Batra SK. Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas. World Journal of Clinical Oncology. 3: 32-42. PMID 22442756 DOI: 10.5306/wjco.v3.i3.32  0.32
2012 Mimeault M, Johansson SL, Batra SK. Pathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progenies. Plos One. 7: e31919. PMID 22384099 DOI: 10.1371/journal.pone.0031919  0.8
2012 Torres MP, Chakraborty S, Souchek J, Batra SK. Mucin-based targeted pancreatic cancer therapy. Current Pharmaceutical Design. 18: 2472-81. PMID 22372499  0.8
2012 Tarang S, Kumar S, Batra SK. Mucins and toll-like receptors: kith and kin in infection and cancer. Cancer Letters. 321: 110-9. PMID 22306702 DOI: 10.1016/j.canlet.2012.01.040  0.8
2012 Higashi M, Yamada N, Yokoyama S, Kitamoto S, Tabata K, Koriyama C, Batra SK, Yonezawa S. Pathobiological implications of MUC16/CA125 expression in intrahepatic cholangiocarcinoma-mass forming type. Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology. 79: 101-6. PMID 22286058 DOI: 10.1159/000335164  0.8
2012 Seshacharyulu P, Ponnusamy MP, Haridas D, Jain M, Ganti AK, Batra SK. Targeting the EGFR signaling pathway in cancer therapy. Expert Opinion On Therapeutic Targets. 16: 15-31. PMID 22239438 DOI: 10.1517/14728222.2011.648617  0.88
2012 Senapati S, Gnanapragassam VS, Moniaux N, Momi N, Batra SK. Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells. Oncogene. 31: 3346-56. PMID 22105367 DOI: 10.1038/onc.2011.505  0.8
2012 Kaur S, Venktaraman G, Jain M, Senapati S, Garg PK, Batra SK. Recent trends in antibody-based oncologic imaging. Cancer Letters. 315: 97-111. PMID 22104729 DOI: 10.1016/j.canlet.2011.10.017  0.56
2011 Tong Z, Chakraborty S, Sung B, Koolwal P, Kaur S, Aggarwal BB, Mani SA, Bresalier RS, Batra SK, Guha S. Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells. Cancer. 117: 2408-18. PMID 24048788 DOI: 10.1002/cncr.25803  0.56
2011 Baine MJ, Menning M, Smith LM, Mallya K, Kaur S, Rachagani S, Chakraborty S, Sasson AR, Brand RE, Batra SK. Differential gene expression analysis of peripheral blood mononuclear cells reveals novel test for early detection of pancreatic cancer. Cancer Biomarkers : Section a of Disease Markers. 11: 1-14. PMID 22820136 DOI: 10.3233/CBM-2012-0260  0.8
2011 Haridas D, Chakraborty S, Ponnusamy MP, Lakshmanan I, Rachagani S, Cruz E, Kumar S, Das S, Lele SM, Anderson JM, Wittel UA, Hollingsworth MA, Batra SK. Pathobiological implications of MUC16 expression in pancreatic cancer. Plos One. 6: e26839. PMID 22066010 DOI: 10.1371/journal.pone.0026839  0.8
2011 Dey P, Ponnusamy MP, Deb S, Batra SK. Human RNA polymerase II-association factor 1 (hPaf1/PD2) regulates histone methylation and chromatin remodeling in pancreatic cancer. Plos One. 6: e26926. PMID 22046413 DOI: 10.1371/journal.pone.0026926  0.88
2011 Jain M, Venkatraman G, Moniaux N, Kaur S, Kumar S, Chakraborty S, Varshney GC, Batra SK. Monoclonal antibodies recognizing the non-tandem repeat regions of the human mucin MUC4 in pancreatic cancer. Plos One. 6: e23344. PMID 21886786 DOI: 10.1371/journal.pone.0023344  0.8
2011 Mimeault M, Batra SK. Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy. Chinese Medicine. 6: 31. PMID 21859497 DOI: 10.1186/1749-8546-6-31  0.8
2011 Baine M, Sahak F, Lin C, Chakraborty S, Lyden E, Batra SK. Marital status and survival in pancreatic cancer patients: a SEER based analysis. Plos One. 6: e21052. PMID 21698253 DOI: 10.1371/journal.pone.0021052  0.44
2011 Chakraborty S, Tarantolo SR, Treves J, Sambol D, Hauke RJ, Batra SK. Progressive Multifocal Leukoencephalopathy in a HIV-Negative Patient with Small Lymphocytic Leukemia following Treatment with Rituximab. Case Reports in Oncology. 4: 136-42. PMID 21691572 DOI: 10.1159/000326851  0.44
2011 Mimeault M, Batra SK. Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies. Brain Pathology (Zurich, Switzerland). 21: 479-500. PMID 21615592 DOI: 10.1111/j.1750-3639.2011.00505.x  0.8
2011 Mimeault M, Batra SK. Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies. Molecular Medicine (Cambridge, Mass.). 17: 949-64. PMID 21607288 DOI: 10.2119/molmed.2011.00115  0.8
2011 Ponnusamy MP, Seshacharyulu P, Vaz A, Dey P, Batra SK. MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells. Journal of Ovarian Research. 4: 7. PMID 21521521 DOI: 10.1186/1757-2215-4-7  0.88
2011 Mimeault M, Batra SK. Animal models relevant to human prostate carcinogenesis underlining the critical implication of prostatic stem/progenitor cells. Biochimica Et Biophysica Acta. 1816: 25-37. PMID 21396984 DOI: 10.1016/j.bbcan.2011.03.001  0.8
2011 Wang G, Lipert RJ, Jain M, Kaur S, Chakraboty S, Torres MP, Batra SK, Brand RE, Porter MD. Detection of the potential pancreatic cancer marker MUC4 in serum using surface-enhanced Raman scattering. Analytical Chemistry. 83: 2554-61. PMID 21391573 DOI: 10.1021/ac102829b  0.8
2011 Baine MJ, Chakraborty S, Smith LM, Mallya K, Sasson AR, Brand RE, Batra SK. Transcriptional profiling of peripheral blood mononuclear cells in pancreatic cancer patients identifies novel genes with potential diagnostic utility. Plos One. 6: e17014. PMID 21347333 DOI: 10.1371/journal.pone.0017014  0.8
2011 Mukhopadhyay P, Chakraborty S, Ponnusamy MP, Lakshmanan I, Jain M, Batra SK. Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy. Biochimica Et Biophysica Acta. 1815: 224-40. PMID 21277939 DOI: 10.1016/j.bbcan.2011.01.001  0.88
2011 Chakraborty S, Bonthu N, Swanson BJ, Batra SK. Role of mucins in the skin during benign and malignant conditions. Cancer Letters. 301: 127-41. PMID 21146919 DOI: 10.1016/j.canlet.2010.11.004  0.8
2011 Senapati S, Chaturvedi P, Chaney WG, Chakraborty S, Gnanapragassam VS, Sasson AR, Batra SK. Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 267-74. PMID 21059814 DOI: 10.1158/1078-0432.CCR-10-1937  0.8
2011 Chakraborty S, Baine MJ, Sasson AR, Batra SK. Current status of molecular markers for early detection of sporadic pancreatic cancer. Biochimica Et Biophysica Acta. 1815: 44-64. PMID 20888394 DOI: 10.1016/j.bbcan.2010.09.002  0.8
2011 Mimeault M, Batra SK. Stem cell applications in disease research: Recent advances in stem cell and cancer stem cell biology and their therapeutic implications Stem Cell Research Journal. 3: 349-388.  0.8
2011 Mimeault M, Batra SK. Novel diagnostic and prognostic biomarkers and molecular therapeutic targets in aggressive, metastatic and recurrent melanomas Metastatic Melanoma: Symptoms, Diagnoses and Treatments. 127-148.  0.8
2011 Mimeault M, Batra SK. Recent progress and related patents on the applications of bone marrow-derived stem/progenitor cells in regenerative medicine and cancer therapies Recent Patents On Regenerative Medicine. 1: 42-59.  0.8
2010 Mimeault M, Batra SK. Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies. Pharmacological Reviews. 62: 497-524. PMID 20716670 DOI: 10.1124/pr.109.002329  0.8
2010 Senapati S, Ho SB, Sharma P, Das S, Chakraborty S, Kaur S, Niehans G, Batra SK. Expression of intestinal MUC17 membrane-bound mucin in inflammatory and neoplastic diseases of the colon. Journal of Clinical Pathology. 63: 702-7. PMID 20702471 DOI: 10.1136/jcp.2010.078717  0.56
2010 Ponnusamy MP, Lakshmanan I, Jain M, Das S, Chakraborty S, Dey P, Batra SK. MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells. Oncogene. 29: 5741-54. PMID 20697346 DOI: 10.1038/onc.2010.309  0.88
2010 Chakraborty S, Ganti AK, Marr A, Batra SK. Lung cancer in women: Role of estrogens Expert Review of Respiratory Medicine. 4: 509-518. PMID 20658912 DOI: 10.1586/ers.10.50  0.8
2010 Murielle M, Batra SK. Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer Journal of Cellular Physiology. 224: 626-635. PMID 20578239 DOI: 10.1002/jcp.22196  0.8
2010 Mimeault M, Batra SK. New advances on critical implications of tumorand metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence Histology and Histopathology. 25: 1057-1073. PMID 20552555  0.8
2010 Bafna S, Kaur S, Batra SK. Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene. 29: 2893-904. PMID 20348949 DOI: 10.1038/onc.2010.87  0.8
2010 Mimeault M, Batra SK. Recent advancements on the identification of immature cancer cells with the stem cell-like properties in different aggressive and recurrent cancer types Anti-Cancer Agents in Medicinal Chemistry. 10: 103. PMID 20344823  0.8
2010 Mimeault M, Batra SK. New promising drug targets in cancer- and mtastasis-initiating cells Drug Discovery Today. 15: 354-364. PMID 20338259 DOI: 10.1016/j.drudis.2010.03.009  0.8
2010 Mimeault M, Johansson SL, Senapati S, Momi N, Chakraborty S, Batra SK. MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies. Cancer Letters. 295: 69-84. PMID 20303649 DOI: 10.1016/j.canlet.2010.02.015  0.8
2010 Mimeault M, Batra SK. Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies Anti-Cancer Agents in Medicinal Chemistry. 10: 137-151. PMID 20184544  0.8
2010 Sadanandam A, Varney ML, Singh S, Ashour AE, Moniaux N, Deb S, Lele SM, Batra SK, Singh RK. High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasis. International Journal of Cancer. Journal International Du Cancer. 127: 1373-83. PMID 20073063 DOI: 10.1002/ijc.25166  0.88
2010 Rachagani S, Kumar S, Batra SK. MicroRNA in pancreatic cancer: Pathological, diagnostic and therapeutic implications Cancer Letters. 292: 8-16. PMID 20004512 DOI: 10.1016/j.canlet.2009.11.010  0.8
2010 Senapati S, Das S, Batra SK. Mucin-interacting proteins: From function to therapeutics Trends in Biochemical Sciences. 35: 236-245. PMID 19913432 DOI: 10.1016/j.tibs.2009.10.003  0.8
2010 Mimeault M, Batra SK. Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies Journal of Cellular and Molecular Medicine. 14: 116-134. PMID 19725922 DOI: 10.1111/j.1582-4934.2009.00885.x  0.8
2010 Mimeault M, Batra SK. Anti-Cancer Agents in Medicinal Chemistry: Editorial Anti-Cancer Agents in Medicinal Chemistry. 10: 103.  0.8
2009 Ponnusamy MP, Deb S, Dey P, Chakraborty S, Rachagani S, Senapati S, Batra SK. RNA polymerase II associated factor 1/PD2 maintains self-renewal by its interaction with Oct3/4 in mouse embryonic stem cells. Stem Cells (Dayton, Ohio). 27: 3001-11. PMID 19821493 DOI: 10.1002/stem.237  0.88
2009 Mimeault M, Batra SK. Aging of tissue-resident adult stem/progenitor cells and their pathological consequences Panminerva Medica. 51: 57-79. PMID 19776709  0.8
2009 Moniaux N, Nemos C, Deb S, Zhu B, Dornreiter I, Hollingsworth MA, Batra SK. The human RNA polymerase II-associated factor 1 (hPaf1): a new regulator of cell-cycle progression. Plos One. 4: e7077. PMID 19771162 DOI: 10.1371/journal.pone.0007077  0.8
2009 Bafna S, Kaur S, Momi N, Batra SK. Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin. British Journal of Cancer. 101: 1155-61. PMID 19738614 DOI: 10.1038/sj.bjc.6605285  0.8
2009 Mimeault M, Batra SK. Characterization of nonmalignant and malignant prostatic stem/progenitor cells by Hoechst side population method Methods in Molecular Biology (Clifton, N.J.). 568: 139-149. PMID 19582424 DOI: 10.1007/978-1-59745-280-9_8  0.8
2009 Mimeault M, Batra SK. Recent insights into the molecular mechanisms involved in aging and the malignant transformation of adult stem/progenitor cells and their therapeutic implications Ageing Research Reviews. 8: 94-112. PMID 19114129 DOI: 10.1016/j.arr.2008.12.001  0.8
2009 Mimeault M, Batra SK. Potential molecular therapeutic targets in cancer stem/progenitor cells: Are ATP-binding cassette membrane transporters appropriate targets to eliminate cancer-initiating cells? Stem Cell Biology in Health and Disease. 385-421. DOI: 10.1007/978-90-481-3040-5_17  0.8
2008 Deb S, Ponnusamy MP, Senapati S, Dey P, Batra SK. Human PAF complexes in endocrine tumors and pancreatic cancer. Expert Review of Endocrinology & Metabolism. 3: 557-565. PMID 30290411 DOI: 10.1586/17446651.3.5.557  0.88
2008 Bafna S, Singh AP, Moniaux N, Eudy JD, Meza JL, Batra SK. MUC4, a multifunctional transmembrane glycoprotein, induces oncogenic transformation of NIH3T3 mouse fibroblast cells. Cancer Research. 68: 9231-8. PMID 19010895 DOI: 10.1158/0008-5472.CAN-08-3135  0.8
2008 Senapati S, Sharma P, Bafna S, Roy HK, Batra SK. The MUC gene family: their role in the diagnosis and prognosis of gastric cancer. Histology and Histopathology. 23: 1541-52. PMID 18830939  0.8
2008 Mimeault M, Batra SK. Recent progress on normal and malignant pancreatic stem/progenitor cell research: Therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer Gut. 57: 1456-1468. PMID 18791122 DOI: 10.1136/gut.2008.150052  0.8
2008 Senapati S, Chaturvedi P, Sharma P, Venkatraman G, Meza JL, El-Rifai W, Roy HK, Batra SK. Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer. British Journal of Cancer. 99: 949-56. PMID 18781152 DOI: 10.1038/sj.bjc.6604632  0.8
2008 Mimeault M, Batra SK. Targeting of cancer stem/progenitor cells plus stem cell-based therapies: The ultimate hope for treating and curing aggressive and recurrent cancers Panminerva Medica. 50: 3-18. PMID 18427384  0.8
2008 Chaturvedi P, Singh AP, Chakraborty S, Chauhan SC, Bafna S, Meza JL, Singh PK, Hollingsworth MA, Mehta PP, Batra SK. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. Cancer Research. 68: 2065-70. PMID 18381409 DOI: 10.1158/0008-5472.CAN-07-6041  0.8
2008 Mimeault M, Batra SK. Recent progress on tissue-resident adult stem cell biology and their therapeutic implications Stem Cell Reviews. 4: 27-49. PMID 18288619 DOI: 10.1007/s12015-008-9008-2  0.8
2008 Wittel UA, Hopt UT, Batra SK. Cigarette smoke-induced pancreatic damage - Experimental data Langenbeck's Archives of Surgery. 393: 581-588. PMID 18193450 DOI: 10.1007/s00423-007-0273-3  0.8
2008 Chaturvedi P, Singh AP, Batra SK. Structure, evolution, and biology of the MUC4 mucin. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 966-81. PMID 18024835 DOI: 10.1096/fj.07-9673rev  0.8
2008 Singh AP, Bafna S, Chaudhary K, Venkatraman G, Smith L, Eudy JD, Johansson SL, Lin MF, Batra SK. Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells. Cancer Letters. 259: 28-38. PMID 17977648 DOI: 10.1016/j.canlet.2007.09.018  0.8
2008 Mimeault M, Hauke R, Batra SK. Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies Clinical Pharmacology and Therapeutics. 83: 673-691. PMID 17786164 DOI: 10.1038/sj.clpt.6100296  0.8
2008 Mimeault M, Batra SK. Recent advances in the development of novel anti-cancer drugs targeting cancer stem/progenitor cells Drug Development Research. 69: 415-430. DOI: 10.1002/ddr.20273  0.8
2007 Mimeault M, Hauke R, Batra SK. Stem cells: A revolution in therapeutics - Recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies Clinical Pharmacology and Therapeutics. 82: 252-264. PMID 17671448 DOI: 10.1038/sj.clpt.6100301  0.8
2007 Chaudhary K, Deb S, Moniaux N, Ponnusamy MP, Batra SK. Human RNA polymerase II-associated factor complex: dysregulation in cancer. Oncogene. 26: 7499-507. PMID 17599057 DOI: 10.1038/sj.onc.1210582  0.88
2007 Moniaux N, Chaturvedi P, Varshney GC, Meza JL, Rodriguez-Sierra JF, Aubert JP, Batra SK. Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells. British Journal of Cancer. 97: 345-57. PMID 17595659 DOI: 10.1038/sj.bjc.6603868  0.8
2007 Andrianifahanana M, Singh AP, Nemos C, Ponnusamy MP, Moniaux N, Mehta PP, Varshney GC, Batra SK. IFN-gamma-induced expression of MUC4 in pancreatic cancer cells is mediated by STAT-1 upregulation: a novel mechanism for IFN-gamma response. Oncogene. 26: 7251-61. PMID 17525742 DOI: 10.1038/sj.onc.1210532  0.8
2007 Jain M, Kamal N, Batra SK. Engineering antibodies for clinical applications Trends in Biotechnology. 25: 307-316. PMID 17512622 DOI: 10.1016/j.tibtech.2007.05.001  0.8
2007 Jain M, Venkatraman G, Batra SK. Cell-penetrating peptides and antibodies: A new direction for optimizing radioimmunotherapy European Journal of Nuclear Medicine and Molecular Imaging. 34: 973-977. PMID 17453198 DOI: 10.1007/s00259-007-0395-4  0.8
2007 Chaturvedi P, Singh AP, Moniaux N, Senapati S, Chakraborty S, Meza JL, Batra SK. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Molecular Cancer Research : McR. 5: 309-20. PMID 17406026 DOI: 10.1158/1541-7786.MCR-06-0353  0.8
2007 Mimeault M, Batra SK. Interplay of distinct growth factors during epithelial-mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies Annals of Oncology. 18: 1605-1619. PMID 17355951 DOI: 10.1093/annonc/mdm070  0.8
2007 Jain M, Venkatraman G, Batra SK. Optimization of radioimmunotherapy of solid tumors: Biological impediments and their modulation Clinical Cancer Research. 13: 1374-1382. PMID 17309914 DOI: 10.1158/1078-0432.CCR-06-2436  0.8
2007 Mimeault M, Batra SK. Functions of tumorigenic and migrating cancer progenitor cells in cancer progression and metastasis and their therapeutic implications Cancer and Metastasis Reviews. 26: 203-214. PMID 17273942 DOI: 10.1007/s10555-007-9052-4  0.8
2007 Singh AP, Chaturvedi P, Batra SK. Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy. Cancer Research. 67: 433-6. PMID 17234748 DOI: 10.1158/0008-5472.CAN-06-3114  0.8
2007 Singh AP, Chauhan SC, Andrianifahanana M, Moniaux N, Meza JL, Copin MC, van Seuningen I, Hollingsworth MA, Aubert JP, Batra SK. MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms. Oncogene. 26: 30-41. PMID 16799633 DOI: 10.1038/sj.onc.1209764  0.8
2006 Wittel UA, Singh AP, Henley BJ, Andrianifahanana M, Akhter MP, Cullen DM, Batra SK. Cigarette smoke-induced differential expression of the genes involved in exocrine function of the rat pancreas. Pancreas. 33: 364-70. PMID 17079941 DOI: 10.1097/01.mpa.0000240601.80570.31  0.8
2006 Andrianifahanana M, Chauhan SC, Choudhury A, Moniaux N, Brand RE, Sasson AA, Pour PM, Batra SK. MUC4-expressing pancreatic adenocarcinomas show elevated levels of both T1 and T2 cytokines: potential pathobiologic implications. The American Journal of Gastroenterology. 101: 2319-29. PMID 17032197 DOI: 10.1111/j.1572-0241.2006.00871.x  0.8
2006 Mimeault M, Batra SK. Concise review: Recent advances on the significance of stem cells in tissue regeneration and cancer therapies Stem Cells. 24: 2319-2345. PMID 16794264 DOI: 10.1634/stemcells.2006-0066  0.8
2006 Moniaux N, Junker WM, Singh AP, Jones AM, Batra SK. Characterization of human mucin MUC17. Complete coding sequence and organization. The Journal of Biological Chemistry. 281: 23676-85. PMID 16737958 DOI: 10.1074/jbc.M600302200  0.8
2006 Moniaux N, Nemos C, Schmied BM, Chauhan SC, Deb S, Morikane K, Choudhury A, Vanlith M, Sutherlin M, Sikela JM, Hollingsworth MA, Batra SK. The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis. Oncogene. 25: 3247-57. PMID 16491129 DOI: 10.1038/sj.onc.1209353  0.8
2006 Andrianifahanana M, Moniaux N, Batra SK. Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochimica Et Biophysica Acta. 1765: 189-222. PMID 16487661 DOI: 10.1016/j.bbcan.2006.01.002  0.8
2006 Wittel UA, Pandey KK, Andrianifahanana M, Johansson SL, Cullen DM, Akhter MP, Brand RE, Prokopczyk B, Batra SK. Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. The American Journal of Gastroenterology. 101: 148-59. PMID 16405548 DOI: 10.1111/j.1572-0241.2006.00405.x  0.8
2006 Singh AP, Chauhan SC, Bafna S, Johansson SL, Smith LM, Moniaux N, Lin MF, Batra SK. Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas. The Prostate. 66: 421-9. PMID 16302265 DOI: 10.1002/pros.20372  0.8
2006 Mimeault M, Batra SK. Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies Carcinogenesis. 27: 1-22. PMID 16195239 DOI: 10.1093/carcin/bgi229  0.8
2005 Andrianifahanana M, Agrawal A, Singh AP, Moniaux N, van Seuningen I, Aubert JP, Meza J, Batra SK. Synergistic induction of the MUC4 mucin gene by interferon-gamma and retinoic acid in human pancreatic tumour cells involves a reprogramming of signalling pathways. Oncogene. 24: 6143-54. PMID 16007204 DOI: 10.1038/sj.onc.1208756  0.8
2005 Standop J, Andrianifahanana M, Moniaux N, Schneider M, Ulrich A, Brand RE, Wisecarver JL, Bridge JA, Büchler MW, Adrian TE, Batra SK, Pour PM. ErbB2 growth factor receptor, a marker for neuroendocrine cells? Pancreatology : Official Journal of the International Association of Pancreatology (Iap) ... [Et Al.]. 5: 44-58. PMID 15775699 DOI: 10.1159/000084490  0.8
2004 Moniaux N, Andrianifahanana M, Brand RE, Batra SK. Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy. British Journal of Cancer. 91: 1633-8. PMID 15494719 DOI: 10.1038/sj.bjc.6602163  0.8
2004 Mimeault M, Bonenfant D, Batra SK. New advances on the functions of epidermal growth factor receptor and ceramides in skin cell differentiation, disorders and cancers Skin Pharmacology and Physiology. 17: 153-166. PMID 15258446 DOI: 10.1159/000078818  0.8
2004 Moniaux N, Varshney GC, Chauhan SC, Copin MC, Jain M, Wittel UA, Andrianifahanana M, Aubert JP, Batra SK. Generation and characterization of anti-MUC4 monoclonal antibodies reactive with normal and cancer cells in humans. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 52: 253-61. PMID 14729877  0.8
2003 Batra SK. Genetically engineered antibody fragments and PET imaging: A new era of radioimmunodiagnosis Journal of Nuclear Medicine. 44: 1970-1972. PMID 14660723  0.8
2003 Pandey KK, Batra SK. RXRα: A novel target for prostate cancer Cancer Biology and Therapy. 2: 185-186. PMID 12750560 DOI: 10.4161/cbt.2.2.282  0.8
2003 Pour PM, Bell RH, Batra SK. Neural invasion in the staging of pancreatic cancer Pancreas. 26: 322-325. PMID 12717262 DOI: 10.1097/00006676-200305000-00002  0.8
2003 Pour PM, Pandey KK, Batra SK. What is the origin of pancreatic adenocarcinoma? Molecular Cancer. 2. PMID 12636873 DOI: 10.1186/1476-4598-2-13  0.8
2002 Pour PM, Standop J, Batra SK. Are islet cells the gatekeepers of the pancreas? Pancreatology. 2: 440-448. PMID 12378111 DOI: 10.1159/000064718  0.8
2002 Khorrami AM, Choudhury A, Andrianifahanana M, Varshney GC, Bhattacharyya SN, Hollingsworth MA, Kaufman B, Batra SK. Purification and characterization of a human pancreatic adenocarcinoma mucin. Journal of Biochemistry. 131: 21-9. PMID 11754731  0.8
2001 Andrianifahanana M, Moniaux N, Schmied BM, Ringel J, Friess H, Hollingsworth MA, Büchler MW, Aubert JP, Batra SK. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 4033-40. PMID 11751498  0.8
2001 Wittel UA, Goel A, Varshney GC, Batra SK. Mucin antibodies - new tools in diagnosis and therapy of cancer Frontiers in Bioscience : a Journal and Virtual Library. 6. PMID 11578978  0.8
2001 Jain M, Karan D, Batra SK, Varshney GC. Mucins in protozoan parasites Frontiers in Bioscience : a Journal and Virtual Library. 6. PMID 11578964  0.8
2001 Goel A, Batra SK. Early changes in islet hormone secretion in the hamster pancreatic cancer model Teratogenesis Carcinogenesis and Mutagenesis. 21: 59-67. PMID 11135321 DOI: 10.1002/1520-6866(2001)21:1<59::AID-TCM6>3.0.CO;2-V  0.8
1997 Ashley DM, Batra SK, Bigner DD. Monoclonal antibodies to growth factors and growth factor receptors: their diagnostic and therapeutic potential in brain tumors. Journal of Neuro-Oncology. 35: 259-73. PMID 9440024 DOI: 10.1023/A:1005812417638  0.8
1992 Batra SK, Metzgar RS, Hollingsworth MA. Human muc 1 mucin gene expression in the fetal pancreas Pancreas. 7: 391-393. PMID 1594562  0.8
1992 Hollingsworth MA, Batra SK, Qi WN, Yankaskas JR. MUC1 mucin mRNA expression in cultured human nasal and bronchial epithelial cells American Journal of Respiratory Cell and Molecular Biology. 6: 516-520. PMID 1581075  0.8
1992 Batra SK, Metzgar RS, Worlock AJ, Hollingsworth MA. Expression of the human MUC1 mucin cDNA in a hamster pancreatic tumor cell line HP-1 International Journal of Pancreatology. 12: 271-283. PMID 1289420 DOI: 10.1007/BF02924367  0.8
1991 Batra SK, Metzgar RS, Hollingsworth MA. Molecular cloning and sequence analysis of the human ribosomal protein S16 Journal of Biological Chemistry. 266: 6830-6833. PMID 2016298  0.8
1991 Batra SK, Metzgar RS, Hollingsworth MA. A simple, effective method for the construction of subtracted cDNA libraries Genetic Analysis Techniques and Applications. 8: 129-133. PMID 1878262 DOI: 10.1016/1050-3862(91)90029-Q  0.8
1991 Batra SK, Metzgar RS, Hollingsworth MA. Isolation and characterization of a complementary DNA (PD-1) differentially expressed by human pancreatic ductal cell tumors Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 2: 385-390. PMID 1793733  0.8
1991 Batra SK, Hollingsworth MA. Expression of the human mucin gene, Muc 1, in normal tissues and metastatic pancreatic tumors International Journal of Pancreatology. 10: 287-292. PMID 1787340 DOI: 10.1007/BF02924167  0.8
Show low-probability matches.